Gunjan Jadon | Medicinal Chemistry | Women Researcher Award

Dr. Gunjan Jadon | Medicinal Chemistry | Women Researcher Award

Professor | Pacific College of Pharmacy | India

Dr. Gunjan Jadon is an emerging researcher in pharmaceutical analysis and analytical chemistry, known for her contributions to quality-centered method development and scientific rigor. With a growing academic profile reflected through 3 peer-reviewed publications, 54 citations, and an h-index of 2, she has steadily established her presence within the analytical science community. Her research focuses on chromatographic method development, impurity assessment, pharmaceutical quality control, and the systematic application of Analytical Quality by Design (QbD) principles. One of her notable works includes the development and validation of a QbD-based RP-HPLC method for the quantification of dobutamine, demonstrating her expertise in experimental optimization, response-surface modeling, and regulatory aligned method validation. Dr. Jadon’s broader research interests integrate risk assessment, analytical robustness studies, and the enhancement of method precision and reproducibility to support high-quality pharmaceutical evaluation. She actively collaborates with multidisciplinary teams of pharmaceutical scientists and analytical chemists, strengthening the practical and translational impact of her findings. Her work contributes to improving drug-evaluation workflows, ensuring analytical reliability, and promoting safer therapeutic outcomes across the pharmaceutical sector. Beyond her research outputs, she remains engaged in scientific dialogue through collaborative networks, co-authored studies, and participation in academic platforms aimed at advancing analytical science. Her contributions hold societal relevance by supporting the development of robust analytical frameworks that enhance the quality, safety, and consistency of pharmaceutical products. Driven by a commitment to scientific integrity and continuous innovation, Dr. Jadon continues to explore emerging analytical challenges while expanding the methodological landscape of pharmaceutical research, demonstrating promise as a dedicated and impactful early-career scientist.

Featured Publications

1. Dahiya, R., Dahiya, S., Fuloria, N. K., Kumar, S., Mourya, R., Chennupati, S. V., et al. (2020). Natural bioactive thiazole-based peptides from marine resources: Structural and pharmacological aspects. Marine Drugs, 18(6), 329.

2. Joshi, S. K., Bhadauria, R. S., & Diwaker, A. K. (2012). Introduction to neoplasm: Tumor classification – A review article. International Journal of Advanced Research in Pharmaceutical & Bio Sciences, 22.

3. Jadon, G., & Kumawat, L. (2011). Synthesis, spectral and biological evaluation of some phenyl acetic acid hydrazone derivatives. International Journal of Pharmaceutical Sciences and Research, 2(10), 2572.

4. Gunjan, J., & Kumawat, L. (2011). Synthesis, spectral and biological evaluation of some hydrazone derivatives. International Journal of Pharmaceutical Sciences and Research, 2(9), 2408–2412.

5. Gunjan, J., Rahul, N., Divya, S., Praveen, K. S., & Diwaker, K. A. (2012). Antioxidant activity of various parts of Punica granatum: A review. Journal of Drug Delivery & Therapeutics, 2, 138–141.

Gunjan Jadon’s work advances analytical chemistry and pharmaceutical quality assurance by developing robust, regulatory-aligned methods that improve drug safety and evaluation. Her research contributes to more reliable therapeutic quality control, supporting innovation, precision, and societal well-being across the pharmaceutical sector.

Limin Gu | Medicinal Chemistry | Best Research Article Award

Prof. Dr. Limin Gu | Medicinal Chemistry | Best Research Article Award

Associate Professor | Hebei University of Science and Technology | China

Prof. Dr. Limin Gu is a distinguished Associate Professor and a leading researcher in the field of flame retardant materials and materials science and engineering. She has made significant contributions to advancing sustainable flame-retardant technologies through her work at the College of Chemical and Pharmaceutical Engineering, Hebei University of Science & Technology, and as an active member of the Research Center for Chemical Safety & Security and Verification Technology. Her research focuses on intrinsically flame-retardant polymer synthesis, bio-based halogen-free flame retardants, graphene functionalization, and computer vision-assisted chemical analysis. With strong expertise in analytical techniques such as GC, GC-MS, HPLC, TGA, and TG-IR, she effectively integrates experimental and applied approaches in her studies. Prof. Gu has authored more than 20 scientific publications in prestigious journals including European Polymer Journal, Journal of Thermal Analysis and Calorimetry, and Journal of Applied Polymer Science, and has also published a scholarly monograph on flame-retardant waterborne polyurethane materials. Her innovative research has led to over ten awarded Chinese patents related to bio-based flame retardants, phosphonium compounds, and multifunctional polymeric materials, highlighting her dedication to developing eco-friendly and high-performance flame-retardant systems. Recognized for her scientific excellence and contributions to sustainable materials development, Prof. Gu continues to influence the advancement of green chemistry and polymer innovation. Her growing academic impact is demonstrated by 227 citations, 17 documents, and an h-index of 8, reflecting her emerging leadership and meaningful contributions to the global materials science community.

Profiles : Scopus | ORCID | ResearchGate

Featured Publications

Gu, L., Shi, Y., Liu, W., Zhang, L., & Ge, Y. (2025). Synthesis and characterization of the hemicellulose-based “three sources into one” intumescent flame retardant and its modification on cellulose. Journal of Thermal Analysis and Calorimetry, 150(12), 9105-9119.

Abdelhadi Boussena | Molecular Biology | Best Researcher Award

Dr. Abdelhadi Boussena | Molecular Biology | Best Researcher Award

chlef university , Algeria.

🔬 Short Biography 🌿💊📚

Abdelhadi Boussena 🎓 is a dedicated microbiologist 🧫 from Algeria 🇩🇿 with a passion for scientific research and academic development. Holding a Ph.D. in Microbiology from Abdelhamid Ibn Badis University, Mostaganem, he has built his expertise in parasitology, microbial ecology, and antibacterial properties of medicinal plants 🌿. His academic path reflects consistent excellence, starting with a Bachelor’s and Master’s in Microbiology from Hassiba Ben Bouali University, Chlef. Professionally, he has served as a pharmacy assistant and contributed to the academic community through student supervision and course instruction 🧑‍🏫. Boussena has published and presented multiple research studies focusing on antibacterial and antioxidant properties of natural extracts 🧪. Fluent in Arabic and competent in French 🇫🇷 and English 🇬🇧, he combines solid communication skills with a calm and problem-solving approach. His ambition is to continue expanding knowledge in microbiology and contribute to global scientific advancement 🌍.

PROFILE 

ORCID 

🔍 Summary of Suitability:

Dr. Abdelhadi Boussena demonstrates a clear and consistent dedication to microbiological research, particularly in the exploration of bioactive compounds from medicinal plants 🌿. His work targets globally significant challenges such as antibiotic resistance, biofilm inhibition, and natural antioxidant discovery, aligning closely with public health priorities and sustainable scientific innovation 🌍. Through his publications, participation in international symposia, and academic involvement in student mentorship and teaching 🧑‍🏫, he exemplifies qualities of a committed and impactful researcher.

📘 Education & Experience

Education:

  • 📚 Ph.D. in Microbiology – Abdelhamid Ibn Badis University, Mostaganem (2019)

  • 📘 Master of Science in Microbiology – Hassiba Ben Bouali University, Chlef

  • 🧬 Bachelor of Science in Parasitology and Microbiology – Hassiba Ben Bouali University, Chlef

Experience:

  • 💊 Pharmacy Assistant – Chlef, Algeria (2016–2017)

  • 🧑‍🏫 Teaching in microbial ecology & systematics (2022)

  • 🧑‍🎓 Co-supervised Master’s students (2019–2022)

  • 🌿 Researcher in medicinal plant valorization

Professional Development 🚀📖

Abdelhadi Boussena’s career reflects a strong commitment to continuous professional development and academic excellence 📖. He actively engages in research focused on microbiological applications of medicinal plants 🌱, exploring their antibacterial and antioxidant properties. His teaching role includes guiding students in microbial ecology and systematics 🧫, demonstrating both pedagogical skills and scientific depth. Boussena has presented at multiple national and international symposia 🎤, broadening his academic network and knowledge base. He has authored peer-reviewed articles on topics such as the phytochemical properties of Ephedra alata and Haloxylon scoparium 📄. His work aims to combat multidrug-resistant pathogens, contributing to public health and environmental sustainability 🧬🌍. Through collaboration, publications, and supervision, he demonstrates leadership and mentorship. His ability to adapt to new scientific methods and share knowledge makes him an asset in microbiology and natural product research 💡.

Research Focus 🔍🤖

Dr. Abdelhadi Boussena’s research centers on the microbiological evaluation of medicinal plants 🌿 for their therapeutic potential against resistant bacterial strains 🦠. His work integrates phytochemical screening, antibacterial and antioxidant assays to identify bioactive compounds from Algerian flora such as Ephedra alata and Haloxylon scoparium 🌵. This research plays a pivotal role in addressing global health concerns related to antibiotic resistance 🧫. He is particularly interested in nosocomial pathogens and biofilm-forming bacteria like Staphylococcus aureus and Pseudomonas aeruginosa 🧪. His methods include agar dilution and phenolic content analysis to evaluate extract potency. Boussena also explores the ecological and sustainable development implications of his findings 🌎. His work contributes to green chemistry and integrative medicine, positioning him at the intersection of environmental microbiology, pharmacognosy, and public health 💊. Through experimentation and collaboration, his ultimate goal is to harness nature’s pharmacy for modern therapeutic solutions.

Awards and Honors 🏆🎖️

  • 🏆 Participant – First National Seminar on Nutrition and Health

  • 🥇 Presenter – 1st International Symposium on Environment & Sustainable Development

  • 🧪 Speaker – National Seminar on Biodiversity of Fauna and Flora in Algeria (2022)

  • 📄 Published – International Journal of Human Settlements (Antibiofilm Study)

  • 📘 Published – Journal of Applied Biological Sciences (Phytochemical Analysis)

Publications & Citations 📚

📘 “Evaluation of the antioxidant activity of the hydro-methanolic extract of Ephedra alata (Ephedraceae)” – Published: 2020 📅 | Citation info: Not listed 📉 | 🧪🌿🧫

📘 “Activité antibactérienne des deux extraits d’Ephedra alata sur une bactérie entérique à Gram négatif…” – Published: 2021 📅 | Citation info: Not listed 📉 | 🦠🔬🌱

📘 “Activités antibactériennes et antibiofilms des souches de lactobacilles vis-à-vis Staphylococcus aureus, Pseudomonas aeruginosa, Bacillus subtilis, B. cereus – Published in International Journal of Human Settlements, Year: Unknown 📅 | Citation info: Not listed 📉 | 🧫🧪🧬

📘 “Phytochemical screening, phenolic content and antioxidant activity of Haloxylon scoparium – Published: 2022 📅 | Citation info: Not listed 📉 | 🌿🧪🧬

📘 “Screening of phytochemicals, evaluation of phenolic content, antibacterial and antioxidant activities of Ephedra alata from Algerian Sahara” – Published: 2022 📅 | Citation info: Not listed 📉 | 🌵🧪🔬

📘 “Use of Haloxylon scoparium Against Multidrug-Resistant Bacteria from Urinary Tract Infections” – Published: Unknown 📅 | Citation info: Not listed 📉 | 💊🦠🌱

🔍 Conclusion:

Dr. Abdelhadi Boussena’s research is both scientifically relevant and socially impactful, addressing critical issues in antimicrobial resistance through eco-conscious methods. His proactive involvement in academia and sustained research output make him highly suitable for recognition through a Best Researcher Award. His work bridges microbiology and pharmacognosy, fostering innovation and contributing to the global effort for sustainable and effective health solutions. 🏆

 

 

 

Waldo Ullah | Biochemical Pharmacology | Best Researcher Award

Prof. Dr. Waldo Ullah | Biochemical Pharmacology | Best Researcher Award

Assistant professor at Pontifical Catholic University of Valparaíso, Chile.

🔬 Short Biography 🌿💊📚

Dr. Waldo Acevedo Castillo 🧑‍🔬 is an Associate Professor at the Institute of Chemistry, Faculty of Science, Pontificia Universidad Católica de Valparaíso 🇨🇱. With a Ph.D. and M.Sc. in Engineering Sciences from Pontificia Universidad Católica de Chile 🎓, Dr. Acevedo has established himself as a pioneer in food chemistry and structural bioinformatics 🧪. His research focuses on the molecular characterization of organoleptic food additives 🍬 and rational drug design 💊. He has published extensively in high-impact journals and contributed to multiple interdisciplinary projects in biochemistry and pharmacology. Passionate about teaching and mentoring 👨‍🏫, he guides undergraduate and graduate students in bioinformatics and biochemical research. Dr. Acevedo also plays an active role in academic peer review, editorial boards, and science outreach 🌍. His career blends deep scientific inquiry with educational innovation and societal engagement, making him a dynamic force in the global chemistry community 🌐.

PROFILE 

SCOPUS 

ORCID 

🔍 Summary of Suitability:

Dr. Waldo Acevedo Castillo exemplifies the qualities of an outstanding researcher, with a strong foundation in computational bioinformatics, food chemistry, and biochemical pharmacology. As an Associate Professor at Pontificia Universidad Católica de Valparaíso, he has consistently demonstrated academic excellence, interdisciplinary innovation, and impactful research. His academic background, scientific publications, mentorship, and leadership roles underscore a career devoted to advancing molecular science and contributing to global health and nutrition challenges.

📘 Education & Experience

  • 🎓 Ph.D. in Engineering Sciences, Pontificia Universidad Católica de Chile (2017)

  • 🎓 M.Sc. in Engineering, Pontificia Universidad Católica de Chile (2016)

  • 📚 Diploma in University Teaching, PUCV (2019)

  • 📚 Diploma in Virtual University Training, PUCV (2020)

  • 💻 Graduate in Bioinformatics, Universidad de Talca (2009)

  • 👨‍🏫 Associate Professor, Institute of Chemistry, PUCV

  • 🧬 Bioinformatics Engineer, Universidad de Talca (2009)

  • 📖 Scientific Reviewer, multiple journals including Food Chemistry and Scientific Reports

  • 🔬 Editorial Board Member, Pharmaceutics and Drug Innovation, Journal of Drug Design and Research

Professional Development 🚀📖

Dr. Waldo Acevedo continuously enhances his professional skills through diverse academic and research activities 📈. He has completed numerous training programs in virtual education, AI in teaching, curriculum development, and project formulation at PUCV 🎓. His involvement in interdisciplinary projects spans vertical farming 🌿, enzymatic hydrolysis, and drug formulation for dermatological conditions 🧴. As a mentor, he has supervised numerous undergraduate and postgraduate theses 🧑‍🎓. Dr. Acevedo actively contributes to international research communities as a reviewer and editorial board member 📰. He is also a dedicated science communicator, promoting STEM outreach through the Explora Academies of Research and School Innovation 🧠. His collaborative spirit has led to roles in national research grants and innovation-driven projects 💡. His work bridges cutting-edge science, education, and public engagement, positioning him as a multifaceted professional in molecular chemistry, bioinformatics, and pharmacological sciences 🌍.

Research Focus 🔍🤖

Dr. Waldo Acevedo’s research centers around Food Chemistry, Biochemical Pharmacology, and Structural Bioinformatics 🔍. He investigates the molecular interactions of food additives, especially sweeteners, with human taste receptors 🍭. His research applies computational tools like molecular docking and dynamics to understand taste perception and improve food quality. Additionally, Dr. Acevedo explores the rational design of anticancer and antimicrobial agents 🧬, targeting enzymes and proteins like SIRT2, EGFR, COX-2, and bitter taste receptors. He has participated in drug discovery efforts and virtual screening campaigns that integrate in silico and in vitro approaches 💊. His interdisciplinary projects have included work on skin microbiome modulation, environmental toxicology, and salmon immunology 🐟. With a strong computational background, he brings innovation to molecular modeling, offering insights into bioactive compound mechanisms and receptor-ligand interactions 🔬. His research contributes significantly to both health and food sciences 🌿.

Awards and Honors 🏆🎖️

  • 🧑‍⚖️ Peer Evaluator, CNA-Chile Postgraduate Area (2024–Present)

  • 🧠 Advisory Committee Member, Explora Academies of Research and School Innovation (2024–Present)

  • 🧬 Review Editor, Frontiers in Genome Editing (2024–Present)

  • 📝 Editorial Board Member, Pharmaceutics and Drug Innovation & Journal of Drug Design and Research (2023–Present)

  • 🌐 Chief of Outreach, Institute of Chemistry, PUCV (2023–Present)

  • 🧪 Member, Society of Biochemistry and Molecular Biology of Chile (SBBMCh) (2022–Present)

  • 📚 Board Collaborator, Doctorate Program in Chemistry, PUCV (2018–Present)

  • 🏆 Best Graduate Award, Universidad de Talca (2009)

  • 🌟 Stimulus to Effort Award, Gabriel & Mary Mustakis Foundation (1999)

  • 🗣️ CONICYT Doctoral Scholarship, Chile (2013–2016)

  • 🇬🇧 CORFO English Scholarship, for Global Services Industry (2010)

Publications & Citations 📚

  • Golcienė, B., Kavaliauskas, P., Acevedo, W., et al. (2025).
    Identification of 3-[(4-Acetylphenyl)(4-Phenylthiazol-2-Yl)Amino]Propanoic Acid Derivatives as Promising Anticancer Candidates Targeting SIRT2 and EGFR.
    Pharmaceuticals, 18(5). https://doi.org/10.3390/ph18050733

  • Kavaliauskas, P., Acevedo, W., et al. (2025).
    3,3′-((3-Hydroxyphenyl)azanediyl)dipropionic Acid Derivatives Against Drug-Resistant Pathogens and Cancer.
    Pathogens, 14(5), 484. https://doi.org/10.3390/pathogens14050484

  • Maldonado, J., Oliva, A., Guzmán, L., Molinari, A., Acevedo, W. (2024).
    Synthesis and Anticancer Activity of Hydroquinone-Chalcone-Pyrazoline Hybrids.
    International Journal of Molecular Sciences, 25, 7281. https://doi.org/10.3390/ijms25137281

  • Kavaliauskas, P., Acevedo, W., et al. (2024).
    Bis(thiazol-5-yl)phenylmethane Derivatives Against MDR Staphylococcus aureus.
    PLOS ONE, 19(3), e0300380. https://doi.org/10.1371/journal.pone.0300380

  • Maldonado, J., Oliva, A., Molinari, A., Acevedo, W. (2023).
    Naphthohydroquinone-Derived Chalcones as Anticancer Agents.
    Molecules, 28, 7172. https://doi.org/10.3390/molecules28207172

  • Acevedo, W., Morán-Figueroa, R., Vargas-Chacoff, L., Morera, F. J., Pontigo, J. P. (2023).
    NLRP3 Inflammasome in Salmo salar: Structural and Transcriptomic Insights.
    International Journal of Molecular Sciences, 24, 14556. https://doi.org/10.3390/ijms241914556

  • Maldonado, J., Acevedo, W., et al. (2022).
    Naphthoisoxazolequinone Carboxamides as Antitumor Agents.
    Polycyclic Aromatic Compounds, 42(4), 1–24. https://doi.org/10.1080/10406638.2022.2095410

  • Kavaliauskas, P., Acevedo, W., et al. (2022).
    Naphthoquinone Derivatives Targeting COX-2.
    Pharmaceuticals, 15, 541. https://doi.org/10.3390/ph15050541

  • Balada, C., Castro, M., Fassio, C., Zamora, A., Marchant, M. J., Acevedo, W., Guzmán, L. (2021).
    Genetic Diversity of Curcuma longa from Rapa Nui.
    Saudi Journal of Biological Sciences, 28, 707–716. https://doi.org/10.1016/j.sjbs.2020.10.062

  • Acevedo, W., Cañón, P., Gómez, F., Huerta, J., Aguayo, D., Agosin, E. (2020).
    L-Malate Protonation and Malolactic Enzyme Activity in Oenococcus oeni.
    Molecules, 25(15), 3431–3447. https://doi.org/10.3390/molecules25153431

🔍 Conclusion:

Dr. Waldo Acevedo Castillo stands out as a multidisciplinary researcher whose work bridges computational biology, food sciences, and pharmacology. His contributions have real-world relevance—from drug development to food safety—and his dedication to mentoring and collaborative science magnifies his impact. These attributes align perfectly with the ethos of the Best Researcher Award, making him a strong and deserving candidate for this prestigious recognition.

 

 

James Cook | Medicinal Chemistry | Best Scholar Award

f

Prof. James Cook | Medicinal Chemistry | Best Scholar Award

University Distinguished Professor and Adjunct Professor at UNIVERSITY OF WISCONSIN-MILWAUKEE, United States.

James M. Cook 🧪 is an esteemed scientist and innovator specializing in medicinal chemistry. Based in Milwaukee, WI, he has contributed significantly to drug discovery, particularly in the development of small-molecule treatments for airway hyperresponsiveness and inflammation in asthma. As a key inventor, Cook has collaborated with the UWM Research Foundation to advance intellectual property in pharmaceutical sciences. His research, supported by prestigious grants, has led to groundbreaking advancements in GABA(A) receptor modulators. His dedication to science and innovation continues to shape the future of therapeutic development. 🌍🔬

Professional Profile
Suitability for the Best Scholar Award

James M. Cook is a distinguished medicinal chemist 🧪 with a strong track record of innovative drug discovery and academic excellence. As a professor at the University of Wisconsin-Milwaukee (UWM) 🏛️, he has significantly contributed to pharmaceutical research, particularly in GABA(A) receptor modulators 💊 for treating neurological and respiratory disorders. His pioneering work has led to multiple patents, high-impact publications, and successful collaborations with the pharmaceutical industry ⚕️.

Education 🎓

  • Ph.D. in Medicinal Chemistry – Specialized in drug discovery and organic synthesis 🔬📚
  • Master’s Degree in Chemistry – Focused on molecular design and pharmaceutical sciences 🧪
  • Bachelor’s Degree in Chemistry – Strong foundation in chemical analysis and research 🏛️

Experience 🏆

  • Professor at the University of Wisconsin-Milwaukee (UWM) – Leading research in medicinal chemistry 🏛️👨‍🏫
  • Principal Investigator in Drug Discovery Projects – Developed novel GABA(A) receptor modulators for treating asthma and neurological disorders 💊🔍
  • Inventor & Patent Holder – Contributed to multiple patents in pharmaceutical innovation 📜💡
  • Recipient of Research Grants – Secured funding from NIH, UWM Research Foundation, and private institutions to advance medical research 💰🧠
  • Collaborator with Pharmaceutical Industry – Worked with biotech firms to translate research into real-world treatments ⚕️🏭

 

Professional Development 🚀📖

James M. Cook has continually advanced his expertise in medicinal chemistry 🔬 through groundbreaking research and innovation. As a professor at the University of Wisconsin-Milwaukee (UWM) 🏛️, he has mentored young scientists and led pioneering studies on GABA(A) receptor modulators 💊. His work has earned prestigious research grants 💰, enabling significant contributions to drug discovery. Cook has collaborated with pharmaceutical companies ⚕️ to translate research into practical treatments. With multiple patents and publications 📜, he remains committed to scientific excellence. His dedication to innovation, education, and industry partnerships continues to shape modern therapeutics. 🚀

Research Focus 🔍🤖

James M. Cook specializes in medicinal chemistry 🧪, focusing on the development of GABA(A) receptor modulators for treating neurological and respiratory disorders 🧠💨. His research explores small-molecule drug design to combat asthma, anxiety, and epilepsy ⚕️. With expertise in organic synthesis and pharmaceutical innovation 💡, he has contributed to groundbreaking treatments targeting airway hyperresponsiveness and inflammation 🌬️. His work integrates biochemical analysis, molecular modeling, and clinical applications 🏥. Through academic and industry collaborations 🤝, Cook aims to develop safer and more effective therapeutic agents, enhancing global healthcare solutions. 🌍🔍

Awards & Honors 🏆

  • Prestigious Research Grants 💰 – Funded by NIH, UWM Research Foundation, and private institutions for groundbreaking drug discovery.
  • Patent Holder & Innovator 📜💡 – Recognized for multiple patents in medicinal chemistry and pharmaceutical sciences.
  • Distinguished Professor at UWM 🏛️👨‍🏫 – Honored for excellence in teaching and research contributions.
  • Scientific Contribution Award 🧪🏅 – Acknowledged for advancements in GABA(A) receptor modulators.
  • Industry & Academic Collaboration Recognition 🤝⚕️ – Celebrated for translating research into real-world therapeutic applications.
Publication Top Notes:

📄 Procognitive and neurotrophic benefits of α5-GABA-A receptor positive allosteric modulation in a β-amyloid deposition mouse model of Alzheimer’s disease pathologyNeurobiology of Aging, 2025 – 📑 Cited by: 0

💊 Intravenous Nanoemulsions Loaded with Phospholipid Complex of a Novel Pyrazoloquinolinone Ligand for Enhanced Brain DeliveryPharmaceutics, 2025 – 📑 Cited by: 0

⚕️ Antinociceptive Effects of a2/a3-Subtype-Selective GABAA Receptor Positive Allosteric Modulators KRM-II-81 and NS16085 in Male Rats: Behavioral SpecificityJournal of Pharmacology and Experimental Therapeutics, 2024 – 📑 Cited by: 1

🐵 Evaluation of the sedative-motor effects of novel GABAkine imidazodiazepines using quantitative observation techniques in rhesus monkeysJournal of Psychopharmacology, 2024 – 📑 Cited by: 0

🧬 GABA(A) Receptor Activation Drives GABARAP–Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma TumorsCancers, 2024 – 📑 Cited by: 1

🦠 Development of non-sedating benzodiazepines with in vivo antischistosomal activityAntimicrobial Agents and Chemotherapy, 2024 – 📑 Cited by: 0

🧠 An alpha 5-GABAA receptor positive allosteric modulator attenuates social and cognitive deficits without changing dopamine system hyperactivity in rats exposed to valproic acid in uteroAutism Research, 2024 – 📑 Cited by: 0

🔬 Extrasynaptic Localization Is Essential for α5GABAA Receptor Modulation of Dopamine System FunctioneNeuro, 2024 – 📑 Cited by: 1

💡 New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,5-a][1,4]diazepin-3-yl)oxazole, Provides a Simplified Synthetic Scheme, High Oral Plasma and Brain Exposures, and Produces Antiseizure Efficacy in Mice, and Antiepileptogenic Activity in Neural Networks in Brain Slices from a Patient with Mesial Temporal Lobe EpilepsyACS Chemical Neuroscience, 2024 – 📑 Cited by: 2

KRM–II–81 suppresses epileptiform activity across the neural network of cortical tissue from a patient with pharmacoresistant epilepsyHeliyon, 2024 – 📑 Cited by: 2

📌 Conclusion:

James M. Cook’s outstanding contributions to medicinal chemistry, intellectual property achievements, and academic leadership make him an exceptional candidate for the Best Scholar Award 🏆. His dedication to scientific excellence, innovation, and mentorship has significantly impacted modern therapeutics, making him highly deserving of this honor. 🚀